James R. Kasinger Insider Trading Activity
James R. Kasinger has been net-selling over the last 12 months with 0 purchases and 5 sales across 1 company.
CRSP is the most-traded position with 5 trades. The largest single transaction was a sale of CRSP for $166K on Mar 16, 2026.
Performance Scorecard
Forward stock performance after each transaction by James R. Kasinger. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -0.2% | 60% | 5 |
| 90 days | — | +0.5% | 60% | 5 |
| 120 days | — | +2.1% | 20% | 5 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersCRSP · CRISPR Therapeutics AG
🔒 Subscribe to see trade entries
Pro members see exactly when James R. Kasinger bought and sold CRSP.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Mar 23, 2026 | CRSP | Sell | 3,182 | $46.78 | $149K | −3.3% | General Counsel and Secretary | |
Mar 16, 2026 | CRSP | Sell | 3,450 | $48.26 | $166K | −3.6% | General Counsel and Secretary | |
Mar 11, 2026 | CRSP | Sell | 2,800 | $52.80 | $148K | −3.1% | General Counsel and Secretary | |
Feb 19, 2026 | CRSP | Sell | 2,112 | $52.58 | $111K | −2.4% | General Counsel and Secretary | |
Oct 14, 2025 | CRSP | Sell | 1,076 | $66.60 | $72K | −1.3% | General Counsel and Secretary |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 5 | $646K |
Other insiders at CRISPR Therapeutics AG
4 other tracked filers at CRSP.